While ROR1 expression has been described in other tumour entities such as chronic lymphatic leukaemia, triple negative breast cancer and non‐small lung cancer, this is to our knowledge the first study which investigates ROR1 expression in cSCC. Here, ROR1 is linked to B-cell chronic lymphocytic leukemia.